Drug Product
Excipients & Specialty Ingredients
Regulatory, Tech Transfer & Support Services
Company Overview
About
Tilman S.A. is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Formulation Development, Process Development, Scale-up
Therapeutic Areas
Immunology
Rheumatology
Quick Facts
HQ:Belgium
Founded:1990
Employees:1,158
Capabilities & Services
Core Capabilities
- Peptide Synthesis
- Small Molecule API
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Inhalation
Production Scales
Phase II
Clinical
Pilot Scale
Markets Served
North America
Europe
International Regulatory
EU GMP Certificates
6
Regulatory Bodies
EMA/EudraGMDP
Regulatory Approvals
Drug Approval EGNF7W
Health Canada · #APR-AKNZE47L · 2020-12-01
Drug Approval R1JE69
PMDA · #APR-B6RYSN76 · 2018-04-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
ISO 9001:2015
International Organization for Standardization
Cert #: CERT-VT7JL9LJ
Issued: 2020-05-19
Expires: 2025-06-04
WHO GMP
World Health Organization
Cert #: CERT-79LT2E3X
Issued: 2020-10-26
Expires: 2025-11-25
Loading CDMO intelligence...
Key facts about Tilman S.A.
- Tilman S.A. is headquartered in Belgium.
- Tilman S.A. was founded in 1990.
- Tilman S.A. has 1,158 employees.
- Tilman S.A.'s capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.
Find CDMOs like Tilman S.A.
Directory pages this company appears in, each with the full list of matching manufacturers.